Health

Health
Pressrelease: Monoclonal Antibodies Report Market Model - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Monoclonal Antibodies Report Market Model http://www.companiesandmarkets.com/Summary-Market-Report/Monoclonal-Antibodies-Report-Market-Model-42817.asp Introduction The model provides a comprehensive analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into the direction of mAb technology evolution and an analysis of pipeline dynamics. Reasons to Purchase Assess the [more] Pressrelease: Winning Product Launch Strategies - Maximizing sales from new pharmaceutical products - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Winning Product Launch Strategies - Maximizing sales from new pharmaceutical products http://www.companiesandmarkets.com/Summary-Market-Report/Winning-Product-Launch-Strategies-Maximizing-sales-from-new-pharmaceutical-products-42816.asp With pharmaceutical R&D continuing to suffer from declining productivity levels and stagnant returns on investment, effective, flexible and commercially successful new product launches have become more important than ever. How pharma companies drive product uptake and the effectiveness of their competitive positioning during the [more] Pressrelease: The Global HIV AIDS Market Outlook to 2012 - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - The Global HIV AIDS Market Outlook to 2012 http://www.companiesandmarkets.com/Summary-Market-Report/The-Global-HIV-AIDS-Market-Outlook-to-2012-42815.asp Business Intelligence for the Pharmaceutical Industry The portfolio of healthcare management reports are designed to help you make well informed and timely business decisions. We understand the problems facing today´s pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of accurate, up-to-date, [more] Pressrelease: Indication Expansion - Opportunities for successful lifecycle management - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Indication Expansion - Opportunities for successful lifecycle management http://www.companiesandmarkets.com/Summary-Market-Report/Indication-Expansion-Opportunities-for-successful-lifecycle-management-42814.asp Due to shrinking pipelines and rising financial pressures on pharmaceutical companies, indication expansion is an increasingly attractive strategy to expand patient potential and extend market exclusivity. Indication Expansion is a new report that provides in-depth case studies analyzing successful recent indication expansions and emerging trends. This report will [more] Pressrelease: eHealthInsight Series - Online Pharmacies - Implications for the Pharmaceutical Industry - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - eHealthInsight Series - Online Pharmacies - Implications for the Pharmaceutical Industry http://www.companiesandmarkets.com/Summary-Market-Report/eHealthInsight-Series-Online-Pharmacies-Implications-for-the-Pharmaceutical-Industry-42813.asp Introduction Online pharmacies are playing an increasing role in the prescription pharmaceutical industry as patients seek the convenience and in some cases cost benefits that they can provide. However while online pharmacies offer considerable benefits there are also risks attached to their increasing role. Scope Introduction to [more] Pressrelease: RandD Strategies - Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - RandD Strategies - Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity http://www.companiesandmarkets.com/Summary-Market-Report/RandD-Strategies-Incremental-improvements-and-paradigm-shifts-in-strategy-are-both-necessary-to-boost-productivity-42812.asp Introduction Waves of technological advancements have powered significant evolution in R&D from serendipitous drug discovery, through to rational drug design. However, as the low-hanging fruit has been picked, and recent technological advances have failed to yield high numbers of new [more] Pressrelease: Launch Strategies - Analyzing Market Trends and Regulatory Impacts - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Launch Strategies - Analyzing Market Trends and Regulatory Impacts http://www.companiesandmarkets.com/Summary-Market-Report/Launch-Strategies-Analyzing-Market-Trends-and-Regulatory-Impacts-42811.asp Introduction With fewer truly novel products entering the market, combined with increasing developmental time and spend, and declining ROI, successful launches have never been more important for pharmaceutical companies. Therefore, to ensure a successful launch, manufacturers must employ a multitude of timely strategies to ensure their product [more] Pressrelease: Generic Series - An Introduction to the Canadian Generics Market - Key trends and leading companies shaping the market - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Generic Series - An Introduction to the Canadian Generics Market - Key trends and leading companies shaping the market http://www.companiesandmarkets.com/Summary-Market-Report/Generic-Series-An-Introduction-to-the-Canadian-Generics-Market-Key-trends-and-leading-companies-shaping-the-market-42810.asp Introduction The Canadian pharmaceutical market is the 8th largest globally and as such represents an important market for generics manufacturers. Although historically dominated by domestic generics companies, mergers and acquisitions over the last five years have increased [more] Pressrelease: Biosimilars Series - Strategic issues - Potential remains uncertain - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Biosimilars Series - Strategic issues - Potential remains uncertain http://www.companiesandmarkets.com/Summary-Market-Report/Biosimilars-Series-Strategic-issues-Potential-remains-uncertain-42809.asp Introduction Significant barriers to entry into the biosimilars market exist. High up-front investment and the need for specific expertise favor big players. Understanding of the marketplace is critical for success acceptance by key stakeholders is crucial for market uptake of biosimilars and achieving preferential reimbursement status through [more] Pressrelease: Biosimilars Series - Regulatory and development issues hurdles exist but are surmountable - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Biosimilars Series - Regulatory and development issues hurdles exist but are surmountable http://www.companiesandmarkets.com/Summary-Market-Report/Biosimilars-Series-Regulatory-and-development-issues-hurdles-exist-but-are-surmountable-42808.asp Introduction Europe serves as a model for other countries looking to define their own regulatory approval criteria. The US is on the brink of passing legislation to establish a statutory pathway for biosimilars approval but the opposing interests of biosimilar and innovative companies may [more] Pressrelease: Disease Management and Drug Adherence - Strategies to support patients and enhance treatment persistence - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Disease Management and Drug Adherence - Strategies to support patients and enhance treatment persistence http://www.companiesandmarkets.com/Summary-Market-Report/Disease-Management-and-Drug-Adherence-Strategies-to-support-patients-and-enhance-treatment-persistence-42807.asp Introduction Failure to take medication as prescribed significantly increases the risk that patients will experience complications resulting in injury or death, and propagate higher healthcare costs overall. The medical establishment´s approach to adherence is changing as it becomes clear that the responsibility [more] Pressrelease: Business Blogging for Pharma - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Business Blogging for Pharma http://www.companiesandmarkets.com/Summary-Market-Report/Business-Blogging-for-Pharma-42806.asp Introduction Social media are shifting the way that the global economy operates. Internet journals and communities have enabled consumers to communicate their experiences with companies´ products and services to other consumers. A consequence of consumer-generated marketing is that relationship management throughout the lifecycle of a product is taking the place of mass [more] Pressrelease: Patient Empowerment - empowered patients can change healthcare outcomes and impact the pharmaceutical industry - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Patient Empowerment - empowered patients can change healthcare outcomes and impact the pharmaceutical industry http://www.companiesandmarkets.com/Summary-Market-Report/Patient-Empowerment-empowered-patients-can-change-healthcare-outcomes-and-impact-the-pharmaceutical-industry-42805.asp Introduction The report has identified the key trends and events that drive patient empowerment and impact the pharmaceutical industry. These range from the increased access to information via internet and the rising pressures of cost containment through to how patient empowerment is [more] Pressrelease: Pricing and Reimbursement Series - NICE its impact on the UK healthcare system and beyond - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Pricing and Reimbursement Series - NICE its impact on the UK healthcare system and beyond http://www.companiesandmarkets.com/Summary-Market-Report/Pricing-and-Reimbursement-Series-NICE-its-impact-on-the-UK-healthcare-system-and-beyond-42804.asp Introduction NICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had an increasing impact on the availability of new drugs in England and Wales, but has also [more] Pressrelease: Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends http://www.companiesandmarkets.com/Summary-Market-Report/Licensing-Strategies-Examining-Today?s-Pharmaceutical-Licensing-Trends-42803.asp Introduction With Pharma struggling to maintain its pipelines and portfolios with products developed in-house, companies are increasingly turning to licensing. However, the search for late-stage developmental products is becoming tougher and more expensive, and companies are now looking towards licensing earlier-stage compounds. Scope Overview of drivers and resistors of licensing [more] Pressrelease: Barr - PharmaVitae Generics Profile - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Barr - PharmaVitae Generics Profile http://www.companiesandmarkets.com/Summary-Market-Report/Barr-PharmaVitae-Generics-Profile-42802.asp Introduction This analysis examines the historical and forecast performance for Barr in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance. An interactive data and analysis tool provides quantitative and qualitative information. Scope Highlights Reasons to Purchase Benchmark Barr´s performance against key rivals in the [more] Pressrelease: Mylan - PharmaVitae Generics Profile - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Mylan - PharmaVitae Generics Profile http://www.companiesandmarkets.com/Summary-Market-Report/Mylan-PharmaVitae-Generics-Profile-42801.asp Introduction This analysis examines the historical and forecast performance for Mylan in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key branded drugs. An interactive data and analysis tool provides quantitative and qualitative information. Scope Highlights Reasons [more] Pressrelease: Sandoz - PharmaVitae Generics Profile - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Sandoz - PharmaVitae Generics Profile http://www.companiesandmarkets.com/Summary-Market-Report/Sandoz-PharmaVitae-Generics-Profile-42800.asp Introduction This analysis examines the historical and forecast performance for Sandoz in the generic pharmaceutical sector. The profile encompasses global company strategy, generic and biosimilar portfolio and pipeline analysis and assessment of financial performance. An interactive data and analysis tool provides quantitative and qualitative information. Scope Highlights Reasons to Purchase Benchmark Sandoz´s performance against key [more] Pressrelease: Watson - PharmaVitae Generics Profile - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - Watson - PharmaVitae Generics Profile http://www.companiesandmarkets.com/Summary-Market-Report/Watson-PharmaVitae-Generics-Profile-42799.asp Introduction This analysis examines the historical and forecast performance for Watson in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key branded drugs. An interactive data and analysis tool provides quantitative and qualitative information. Scope Highlights Reasons [more] Pressrelease: PharmaVitae Generics - Teva - New Research Report on Companies and Markets www.companiesandmarkets.com adds new report - PharmaVitae Generics - Teva http://www.companiesandmarkets.com/Summary-Market-Report/PharmaVitae-Generics-Teva-42798.asp Introduction This analysis examines the historical and forecast performance for Teva in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key branded drugs. An interactive data and analysis tool provides continually updated quantitative and qualitative [more]